rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2006-8-16
|
pubmed:abstractText |
Our previous study showed that male hepatocellular carcinoma (HCC) patients below 40 years of age had the worst survival in the initial several years, but had the best prognosis thereafter. Thus, it seems that age has a paradoxical influence on the prognosis. To further clarify the issue of age on HCC prognosis, we initiated this study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1478-3223
|
pubmed:author |
pubmed-author:ChangTing-TsungTT,
pubmed-author:ChangchienChi-SinCS,
pubmed-author:ChenChien-HungCH,
pubmed-author:ChenChien-JenCJ,
pubmed-author:ChenDing-ShinnDS,
pubmed-author:ChengKen-ShengKS,
pubmed-author:LeeChuan-MoCM,
pubmed-author:LinHans HsienhongHH,
pubmed-author:LuSheng-NanSN,
pubmed-author:SheuJin-ChuanJC,
pubmed-author:SuWei-WenWW,
pubmed-author:WuShun-ShengSS,
pubmed-author:YangSheng-ShunSS
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
766-73
|
pubmed:meshHeading |
pubmed-meshheading:16911457-Adult,
pubmed-meshheading:16911457-Age Factors,
pubmed-meshheading:16911457-Aged,
pubmed-meshheading:16911457-Biological Markers,
pubmed-meshheading:16911457-Carcinoma, Hepatocellular,
pubmed-meshheading:16911457-Female,
pubmed-meshheading:16911457-Hepatitis B virus,
pubmed-meshheading:16911457-Humans,
pubmed-meshheading:16911457-Liver Neoplasms,
pubmed-meshheading:16911457-Male,
pubmed-meshheading:16911457-Middle Aged,
pubmed-meshheading:16911457-Prognosis,
pubmed-meshheading:16911457-Retrospective Studies,
pubmed-meshheading:16911457-Sex Factors,
pubmed-meshheading:16911457-Survival Analysis,
pubmed-meshheading:16911457-Time Factors,
pubmed-meshheading:16911457-Tumor Markers, Biological
|
pubmed:year |
2006
|
pubmed:articleTitle |
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.
|
pubmed:affiliation |
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|